Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Not applicable Interventional Accepts healthy volunteers Results available

NATRELLE® 410 X-Style and L-Style Breast Implants Continued Access Study

ClinicalTrials.gov ID: NCT01870869

Public ClinicalTrials.gov record NCT01870869. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 9:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01870869
Recruitment status
Terminated
Study type
Interventional
Phase
Not applicable
Lead sponsor
Allergan
Industry
Enrollment
1,951 participants

Conditions and interventions

Interventions

  • Anatomically shaped, silicone-filled breast implants with low height/projection or extra-full projection Device

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 28, 2013
Primary completion
Nov 29, 2015
Completion
Nov 29, 2015
Last update posted
Jun 21, 2020

2013 – 2015

United States locations

U.S. sites
58
U.S. states
23
U.S. cities
48
Facility City State ZIP Site status
Anthony Griffin Beverly Hills California 90211
Laurence Berkowitz Campbell California 95008
Mary Powers Long Beach California 90806
Roy Hong Palo Alto California 94301
Eric Bachelor Pleasanton California 94566
Douglas Reavie San Diego California 92128
Steven Teitelbaum Santa Monica California 90404
Tad Heinz Colorado Springs Colorado 80909
Gary Snider Denver Colorado 80218
Terrence Murphy Englewood Colorado 80113
Orlando De Lucia Farmington Connecticut 06032
Lewis Berger Tampa Florida 33607
Gerard Mosiello Tampa Florida 33647
James Namnoum Atlanta Georgia 30342
Peter Johnson Des Plaines Illinois 60016
Stephen Madry Elk Grove Village Illinois 60007
Janet Turkle Carmel Indiana 46290
Bruce Van Natta Indianapolis Indiana 46290
Christine Kelley-Patteson Indianapolis Indiana 46290
Brad Storm Olathe Kansas 66061
Julene Samuels Louisville Kentucky 40241
Timothy Mickel Monroe Louisiana 71201
Paul Davis Shreveport Louisiana 71105
Bradley Bengtson Grand Rapids Michigan 49503
John Renucci Grand Rapids Michigan 49503
Steven Morris Midland Michigan 48640
Charles Nathan Chesterfield Missouri 63005
Herluf Lund Jr. Chesterfield Missouri 63005
Patricia McGuire Creve Coeur Missouri 63141
Schuyler Meltis Hannibal Missouri 63401
Perry Johnson Omaha Nebraska 68102
Perry Johnson Omaha Nebraska 68118
Peter Hyans Berkeley Heights New Jersey 07922
Isaac Starker Florham Park New Jersey 07932
Peter Hetzler Little Silver New Jersey 07739
Marc Alan Drimmer Princeton New Jersey 08540
Caroline Glicksman Sea Girt New Jersey 08750
Lloyd Gayle New York New York 10021
John Sherman New York New York 10028
Tracy Pfeifer New York New York 10028
Robert Jacobs Port Jefferson Station New York 11776
John Decorato Staten Island New York 10306
Raymond Isakov Cleveland Ohio 44195
Craig Colville Toledo Ohio 43615
Frank Barone Toledo Ohio 43623
Derek Shadid Oklahoma City Oklahoma 73134
Robert Hein Oklahoma City Oklahoma 73134
Mark Jewell Eugene Oregon 97401
John Lettieri Spartanburg South Carolina 29303
Kristina D. O'Shaughnessy Nashville Tennessee 37203
Patrick Maxwell Nashville Tennessee 37212
William Carpenter Dallas Texas 75246
Jeffrey Friedman Houston Texas 77030
Natan Yaker Plano Texas 75093
William Adams University Park Texas 75205
Gloria Duda McLean Virginia 22101
Gavin Dry Bellevue Washington 98005
Allen Gabriel Vancouver Washington 98664

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01870869, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 21, 2020 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01870869 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →